Wellgistics Health Inc. Common Stock (WGRX)

FairStock Score: 27/100 — RISKY

Key Financials

Strengths

• Generates $8 million in annual free cash flow (45.9% yield on market cap)
• Revenue growth of 110.4% demonstrates strong top-line momentum

Concerns

• Weak Piotroski F-Score of 1/9 suggests deteriorating financial quality across multiple dimensions
• Altman Z-Score of -7.3 places it in the financial distress zone—elevated bankruptcy risk

AI Analysis

Wellgistics Health Inc. Common Stock is a micro-cap healthcare company valued at $17 million. Revenue stands at $23 million. From a quality standpoint, Wellgistics shows weak Piotroski F-Score of 1/9 signaling deteriorating fundamentals and distressed Altman Z-Score of -7.3 warrants caution. Growth dynamics show revenue growing at 110.4% and profit growth of -7939.6%. Our composite FairStock Score of 27/100 reflects below-average fundamentals overall. Investors should weigh the business quality against the current price and their own margin of safety requirements.

Bull Case

Wellgistics's 110% revenue growth trajectory could accelerate as it captures additional market share in the healthcare sector. With $8 million in annual free cash flow (45.9% yield), management has ample capital for buybacks, dividends, or accretive acquisitions.

Bear Case

Macro headwinds or sector-specific disruption could pressure margins, particularly if competitive intensity increases in the healthcare space. Regulatory changes, input cost inflation, or demand normalization represent underappreciated risks that could materially impact forward estimates.

Data from SEC filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer